558 / 1068
HDR-EBT – Conclusions
1. HDR-EBT delivers a high dose to the tumor and a limited dose to surrounding
normal tissues
2. In resectable rectal cancer, HDR-EBT is a feasible and safe alternative to EBRT
3. HDR-EBT can be used as a boost technique after EBRT:
-
No increase in toxicity
-
No improved outcome (OS, PFS, LC, distant metastases)
-
However, higher tumor regression grade potentially interesting for organ
preservation strategies
4. Effective palliation can be obtained with HDR-EBT, which is a simple outpatient
procedure
5. In elderly inoperable patients, trials for EBRT + HDR-EBT as a definitive option are
ongoing